Wikidata

(Q46748085)

English

Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group.

scientific article

In more languages

Statements

title
Phase III comparison of vitespen, an autologous tumor-derived heat shock protein gp96 peptide complex vaccine, with physician's choice of treatment for stage IV melanoma: the C-100-21 Study Group (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
18281670
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18281670%20AND%20SRC:MED&resulttype=core&format=json
retrieved
2 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q46748085&oldid=1526990991"